All Sydnexis Articles
-
413Research ReviewResearch Highlights From Day Five of ARVO
May 8, 2026 The Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting is being held in Denver, Colorado, from May 3-7, 2026. Myopia...
-
291Latest Myopia NewsSydnexis Shares Latest STAR Trial Data at AAPOS 2026
March 23, 2026 DEL MAR, Calif. — At the 2026 American Association for Pediatric Ophthalmology and Strabismus (AAPOS) annual meeting, Sydnexis shared...
-
651Editor’s PerspectiveWhen the Data Say Yes but the FDA Says No
The recent FDA decision on SYD-101 has implications on the eye care industry. November 17, 2025 Ashley Wallace Tucker, OD, FAAO, FSLS...
-
1.3KLatest Myopia NewsSydnexis Partner Santen Wins U.K. Approval for Ryjunea to Slow Childhood Myopia
November 6, 2025 DEL MAR, Calif. — Sydnexis‘ partner Santen has announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)...
-
579Latest Myopia NewsSydnexis Shares Pivotal Data from STAR Trial at AMCP Nexus
November 4, 2025 DEL MAR, Calif. — At the Academy of Managed Care Pharmacy (AMCP) Nexus 2025, Sydnexis shared topline results from...
-
731Latest Myopia NewsFDA Delays Approval of Sydnexis’ SYD-101 for Myopia, Asking for More Evidence
October 24, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to...
-
908Latest Myopia News
Sydnexis Receives European Commission Approval of SYD-101
June 6, 2025 DEL MAR, Calif. — Sydnexis‘ proprietary low-dose atropine formulation, SYD-101, has received marketing authorization from the European Commission (EC)....
-
1.3KResearch ReviewResearch Highlights from Day Three of ARVO 2025
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May 4-8, 2025....
-
2.2KLatest Myopia News
Sydnexis Receives Positive Opinion in Europe for SYD-101
April 2, 2025 DEL MAR, Calif. — Sydnexis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
-
1.7KLatest Myopia NewsFDA Accepts New Drug Application for Sydnexis’ SYD-101
March 11, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for...
-
1.3KClinicalWorking Toward an Approved Pharmacological Treatment for Myopia Management
sponsored content December 16, 2024 Privately held, clinical-stage pharmaceutical company, Sydnexis Inc. has recently completed an evaluation of its patented low-dose atropine...
-
1.6KLatest Myopia NewsSydnexis Names Perry J. Sternberg CEO
July 16, 2024 DEL MAR, Calif. — Sydnexis has officially named a new Chief Executive Officer and member of the Board of...
-
2.1KClinicalLow-Dose Atropine: An Effective and Safe Option for Managing Juvenile-onset Myopia
sponsored content March 1, 2024 The evidence supporting the use of topical low-dose atropine in treating juvenile-onset myopia is so strong that...
-
1.4KLatest Myopia NewsErin Horn Named VP, Head of Market Access at Sydnexis
January 19, 2024 SAN DIEGO — Sydnexis announced that Erin Horn has been named the Vice President, Head of Market Access at...
-
2.2KLatest Myopia NewsSydnexis Names Nick Ruth as Chief Commercial Officer
SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
-
2.8KClinicalSafe and Effective Low-Dose Atropine Can Be Stable and Comfortable Too
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...
-
4.1KLatest Myopia NewsSydnexis Secures Series B Financing and Finalizes Licensing Agreement with Santen
August 10, 2021 SAN DIEGO, Calif. — Sydnexis announced that it secured $45 million in Series B Financing, which was led by...
-
3.6KIn The PipelineOIS Hosts Virtual Myopia Innovation Showcase
April 30, 2021 The Ophthalmology Innovation Summit (OIS) hosted a virtual Myopia Innovation Showcase on Thursday, April 29. The session started with...
-
4.5KLatest Myopia NewsOIS to Hold Virtual Myopia Innovation Showcase April 29
April 12, 2021 CLICK HERE to view the presentation after April 29, 2021. The Ophthalmology Innovation Summit (OIS) will host a virtual...
-
6.4KClinicalInvestigational and Early-stage Myopia Interventions – A Farsighted View
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
-
9.0KKey IssuesThe Global Myopia Awareness Coalition: What It Is and Why It Matters
Tens of millions of myopic children around the world need our help.
-
3.5KLatest Myopia NewsJobson Joins Global Myopia Awareness Coalition (GMAC)
Jobson Medical Information will be the official North American media sponsor.
-
6.1KEditor’s PerspectiveThank You, Global Myopia Awareness Coalition
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.